International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. [Read more…] about Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia
“Developing drugs to treat disorders of the central nervous system is famously fraught with difficulty. Several companies, including Pear Therapeutics and Dthera, are taking a wildly different approach: digital therapeutics. These are pieces of software designed to treat disease that are regulated, prescribed and even paid for as if they were drugs … Pear is so far the only company to have brought a digital therapeutic to market – but it is by no means the only company in this space. Akili Interactive hasfiled for FDA approval of AKL-T01, a computer game designed to treat ADHD, and [Read more…] about Trend: Pharma industry warming up to digital therapeutics
We hope you enjoy this slidedeck supporting a fascinating, forward-looking session held at the 2019 SharpBrains Virtual Summit: The Future of Brain Health (March 7–9th). Full recordings are available for purchase here.
10.45am-12.15pm. How to intervene early: Examples in depression, epilepsy and smoking cessation
- Dr. Walter Greenleaf, Research Scientist at Stanford University’s Virtual Human Interaction Lab
- David B. Klein, CEO of Click Therapeutics
- Ana Maiques, CEO of Neuroelectrics
- Chaired by: Avery Bedows, Neurotechnology Specialist at Loup Ventures
We are proud to announce the first wave of confirmed Speakers to share their innovative work and insights at the 2019 SharpBrains Virtual Summit: The Future of Brain Health, to be held May 7–9th, 2019:
Dr. Tom Insel, Co-founder and President of Mindstrong Health
Dr. Ainslie Hatch, Director of Digital Therapeutics at Otsuka Pharmaceutical
David Klein, CEO of Click Therapeutics
Charlie Hartwell, Operating Partner at The Bridge Builders Collaborative
Louis Gagnon, CEO of Total Brain
Dr. Anna Wexler, science writer and PI of the Wexler Lab at UPenn
Dr. Eddie Martucci, Founder and CEO of Akili Interactive Labs
Ana Maiques, CEO of Neuroelectrics
Jan Samzelius, Founder and CEO of NeuraMetrix
Dr. Peter Whitehouse, Professor of Neurology at Case Western Reserve University
Kito Tosetti, CEO of CTF MEG International
Ariel Garten, Founder and Chief Evangelism Officer of InteraXon
Alvaro Fernandez, CEO and Editor-in-Chief of SharpBrains
We can’t wait to discuss and help shape the Future of Brain Health!
Imagine your smartphone can detect early signs of anxiety, depression or Parkinson’s Disease — would you like to know? Who else should know … and not know?
Imagine a videogame cleared by the FDA to treat ADHD or substance abuse — how will doctors prescribe it, patients access it, and insurers pay for it?
Imagine being responsible for the health & wellness of your organization — how will you navigate the growing toolkit of evidence-based interventions such as exercise/ meditation/ sleep apps/ cognitive therapies/ biofeedback/ tDCS?
Imagine investing $100 million to help accelerate brain research and applications — how would you ensure that responsible development meets wise adoption?
Imagine a free annual brain check-up — who should take it, and how could it help prevent/ delay/ treat cognitive decline and Alzheimer’s Disease?
LEARN MORE HERE
Otsuka, Click Therapeutics partner to create therapy for mental illness (Verdict Medical Devices):
“Otsuka Pharmaceutical’s US division Otsuka America has partnered with Click Therapeutics to develop and commercialise a prescription digital therapeutic for treating major depressive disorder (MDD) [Read more…] about Otsuka Pharma and Click Therapeutics enter partnership poised to transform mental healthcare
“Drug makers are making more bets on the nascent field of digital medicine. The latest example: Click Therapeutics announced Monday that it grabbed a $17 million investment led by Sanofi Ventures, the Cambridge, MA-based venture capital arm of the French pharmaceutical giant. [Read more…] about Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest